Ratings Farmacosmo S.p.A.

Equities

COSMO

IT0005487670

Real-time Borsa Italiana Other stock markets 10:33:42 2024-05-20 am EDT			5-day change	1st Jan Change
0.896 ^EUR	+0.67%		+0.67%	+30.61%

May. 15	Farmacosmo, group revenues drop into single digits in first quarter	AN
Apr. 30	ITALY GROWTH WINNERS & LOSERS: Plants at the top; AATech bearish	AN

Summary

From a short-term investment perspective, the company presents a deteriorated fundamental configuration.

Strengths

The stock, which is currently worth 2024 to 0.5 times its sales, is clearly overvalued in comparison with peers.
The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.

Weaknesses

As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
The company has insufficient levels of profitability.
For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
The company's sales previsions for the coming years have been revised downwards, which foreshadows another slowdown in business.
For the past year, analysts have significantly revised downwards their profit estimates.
For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
Over the past four months, analysts' average price target has been revised downwards significantly.
Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.

Ratings chart - Surperformance

Sector: Department Stores

	1st Jan change	Capi.	ESG Refinitiv
FARMACOSMO S.P.A.	+29.74%	37.55M	-
JD.COM, INC.	+22.08%	53.86B	B
COUPANG, INC.	+42.06%	41.12B	-
ALLEGRO.EU S.A.	+17.30%	10.45B	B
WAYFAIR INC.	+8.75%	8.18B	C
ETSY, INC.	-21.07%	7.48B	C
ZOZO, INC.	+13.26%	6.89B	B-
FSN E-COMMERCE VENTURES LIMITED	+1.70%	6.07B	D+
MONOTARO CO., LTD.	+8.38%	5.24B	C
OCADO GROUP PLC	-51.79%	3.78B	B+

Investor Rating

Trading Rating

ESG Refinitiv

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes